Estradiol News
Insulin Secretion and Clearance after Subacute Estradiol Administration in Postmenopausal Women
Context: Data from large clinical trials of postmenopausal women suggest that the incidence of diabetes is reduced in women randomized to estrogen-based hormone therapy when compared with placebo. Whether this is due to an effect...
Effects of the Progesterone Receptor Modulator VA2914 in a Continuous Low Dose on the Hypothalamic-Pituitary-Ovarian Axis and Endometrium in Normal Women: A Prospective, Randomized, Placebo-Controlled Trial
Context: Progestin-only pills, the main hormonal alternative to ethinyl estradiol-containing pills in women bearing vascular risk factors, are poorly tolerated due to irregular bleeding. In contrast, progesterone receptor...
Bradley Pharmaceuticals' Elestrin(TM) Receives New Patent to 2022
Bradley Pharmaceuticals, Inc. today announced that its partner, BioSante Pharmaceuticals was issued a new formulation patent for Elestrin(TM) (estradiol gel 0.06%). Elestrin(TM) was approved in December 2006 by the FDA for the...
Estradiol Guards Against Osteoporosis
Researchers find a novel pathway by which estradiol, the primary estrogen in humans maintains bone density. This function is significant as it aids in avoiding osteoporosis.
Biosante: Tiny Biotech Could Skyrocket with Estrogen Replacement Gel
An insightful reader emailed me (which I highly encourage!) last fall suggesting I look further into Biosante (BPA), a small company devoted to improving drug delivery. This is an excellent example of a missed opportunity by me,...